Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$269M |
| 2 |
Amazon
AMZN
|
+$242M |
| 3 |
Apple
AAPL
|
+$215M |
| 4 |
Amgen
AMGN
|
+$212M |
| 5 |
Citizens Financial Group
CFG
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$210M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$195M |
| 3 |
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
|
+$154M |
| 4 |
MXIM
Maxim Integrated Products
MXIM
|
+$127M |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$115M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.58% |
| 2 | Financials | 13.47% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 10.78% |
| 5 | Industrials | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Playtika
PLTK
$961M
| $13.8M | ﹤0.01% |
497,819
+167,119
| +51% | +$4.16M |
|
1827
AeroVironment
AVAV
$9.59B
| $13.7M | ﹤0.01% |
159,133
+3,331
| +2% | +$322K |
|
1828
Enova International
ENVA
$6.52B
| $13.7M | ﹤0.01% |
396,738
-7,518
| -2% | -$245K |
|
1829
1st Source
SRCE
$2.13B
| $13.7M | ﹤0.01% |
289,284
+20,740
| +8% | +$944K |
|
1830
TriMas Corp
TRS
$1.39B
| $13.7M | ﹤0.01% |
422,192
+11,003
| +3% | +$340K |
|
1831
Palomar
PLMR
$3.37B
| $13.7M | ﹤0.01% |
168,929
+12,502
| +8% | +$1.03M |
|
1832
Allogene Therapeutics
ALLO
$683M
| $13.6M | ﹤0.01% |
530,996
-103,373
| -16% | -$2.45M |
|
1833
Coca-Cola Europacific Partners
CCEP
$47.5B
| $13.6M | ﹤0.01% |
246,813
+12,906
| +6% | +$768K |
|
1834
Acadia Pharmaceuticals
ACAD
$4.89B
| $13.6M | ﹤0.01% |
821,102
-288,267
| -26% | -$5.56M |
|
1835
OFG Bancorp
OFG
$2.26B
| $13.6M | ﹤0.01% |
539,804
+17,962
| +3% | +$413K |
|
1836
Alight
ALIT
$394M
| $13.6M | ﹤0.01% |
+59,188
| New | +$12.5M |
|
1837
Relay Therapeutics
RLAY
$4.37B
| $13.5M | ﹤0.01% |
428,322
+205,352
| +92% | +$6.91M |
|
1838
Extreme Networks
EXTR
$3.16B
| $13.5M | ﹤0.01% |
1,368,028
+131,273
| +11% | +$1.39M |
|
1839
Orion
OEC
$360M
| $13.5M | ﹤0.01% |
738,075
+18,867
| +3% | +$338K |
|
|
ETWO
1840
DELISTED
E2open Parent Holdings
ETWO
| $13.4M | ﹤0.01% |
1,187,149
+496,998
| +72% | +$5.58M |
|
1841
NMI Holdings
NMIH
$3.42B
| $13.4M | ﹤0.01% |
592,439
+4,795
| +0.8% | +$105K |
|
|
VBTX
1842
DELISTED
Veritex Holdings
VBTX
| $13.4M | ﹤0.01% |
340,199
+2,667
| +0.8% | +$92.9K |
|
1843
PJT Partners
PJT
$4.57B
| $13.4M | ﹤0.01% |
169,030
+585
| +0.3% | +$44.8K |
|
|
CLDT
1844
Chatham Lodging
CLDT
$601M
| $13.3M | ﹤0.01% |
1,088,259
-91,449
| -8% | -$1.1M |
|
1845
Astec Industries
ASTE
$975M
| $13.3M | ﹤0.01% |
247,409
+10,268
| +4% | +$606K |
|
1846
Allegro MicroSystems
ALGM
$8.23B
| $13.2M | ﹤0.01% |
414,507
+119,604
| +41% | +$3.52M |
|
1847
Fulgent Genetics
FLGT
$513M
| $13.2M | ﹤0.01% |
147,222
+19,795
| +16% | +$1.8M |
|
1848
Apogee Enterprises
APOG
$888M
| $13.2M | ﹤0.01% |
350,288
-7,080
| -2% | -$284K |
|
|
SILK
1849
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $13.2M | ﹤0.01% |
239,661
+3,181
| +1% | +$166K |
|
1850
Wabash National
WNC
$509M
| $13.2M | ﹤0.01% |
869,818
+43,952
| +5% | +$649K |
|
Similar funds
Charles Schwab's Q3 2021 Portfolio in Review
As of Q3 2021, Charles Schwab held 3,610 positions worth $306B, up 1.6% from $301B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q3 2021 filing shows 202 new, 2,185 increased, 922 reduced and 109 closed positions. Its largest new stake was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M. The largest sale was Vanguard FTSE Emerging Markets ETF, an estimated $210M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q3 2021 buy was iShares Core 1-5 Year USD Bond ETF: 3,548,215 shares worth $181M.
- Charles Schwab added most to Moderna in Q3 2021, an estimated $269M increase.
- Charles Schwab's biggest Q3 2021 reduction was Vanguard FTSE Emerging Markets ETF, cutting an estimated $210M.
- Charles Schwab fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $195M.
- Charles Schwab's ten largest holdings make up 17% of its $306B portfolio in Q3 2021.
- Charles Schwab opened 202 new positions and closed 109 in Q3 2021.
- Charles Schwab's portfolio value rose 1.6% quarter-over-quarter to $306B.
Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.